White House plans to reconfigure HHS, rename it 'Department of Health and Public Welfare'

The Trump administration unveiled plans for a massive restructuring of the federal government on Thursday, June 21, including a move that would move the Supplemental Nutritional Assistance Program (SNAP), known as food stamps, from the U.S. Department of Agriculture (USDA) to HHS, which would then be rebranded as the Department of Health and Public Welfare.

“This effort, along with the recent executive orders on federal unions, are the biggest pieces so far of our plan to drain the swamp,” said Office of Management and Budget Director Mick Mulvaney in a statement. “The federal government is bloated, opaque, bureaucratic and inefficient.”

The plan includes huge initiatives, such as privatizing the postal service and merging the Departments of Labor and Education. In addition to HHS’s renaming, it calls for food safety functions to be consolidated into a single agency within USDA. Currently, the FDA handles some of this oversight.

A newly formed Council on Public Assistance would manage SNAP and Medicaid, with the power to impose work requirements to receive these benefits.

Prospects for such an overhaul to pass through Congress appear to be slim. Sen. Pat Murray, D-Washington, the ranking Democrat on the Senate Health Education, Labor and Pensions committee, dismissed the plan immediately.   

“Democrats and Republicans in Congress have rejected President Trump’s proposals to drastically gut investments in education, health care, and workers—and he should expect the same result for this latest attempt to make government work worse for the people it serves,” she said.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.